Through our capital resources and broad network of industry relationships, we offer our investors a well-balanced portfolio of assets, comprised of opportunistic companies within the industry.
Founded in 2019, Cannapharma Investments Inc. is a vertically integrated investment company, that invests in businesses operating in and around the burgeoning Medical Cannabis and Psychedelics industry (“Industry”) and offers accredited investors a professionally managed vehicle to get involved in this rapidly growing space.
Our investments stem across the value chain of the Industry; because we believe ancillary businesses are critical to facilitate the growth. Accordingly, our portfolio aims to cover complementary biotechnology and agri-tech assets as well.
Through our capital resources and broad network of Industry relationships, we offer our investors a well-balanced portfolio of assets, comprised of opportunistic companies within the Industry.
Our portfolio companies are able to leverage off one another and collaborate to execute successful business plans. Our advisors and Industry relationships bring together the knowledge and expertise to help our portfolio thrive in the dynamic and fast-growing environment.
Considering the Industry is going through its early-stage, which is expected to become a globally disruptive field and span a wide range of applications across medical, nutraceutical, consumer products and bio-agritech space, we believe that long-term success in the space requires the ability to simultaneously navigate short-term obstacles and opportunities while maintaining a forward-looking perspective focused on operational efficiency and sustainable value creation.
Significant opportunities exist to invest, requiring the engagement of neutral third parties to ensure accurate, timely, and competent compliance with various state and federal regulatory authorities. Cannapharma team and engaged network of advisors possess significant experience and know-how, which are “sine qua non” to succeed in this dynamic space.
Value Chain Coverage
Extensive Industrial Relationship
Leveraging our intellectual capital, operating backgrounds, and deep network to invest in companies throughout various subsectors and verticals of the Industry, our experience allow us to be the partner of choice for investors throughout this rapidly growing and evolving environment.
Value Chain Concentration:
• Supplement & Drug Development
• Agriculture Technology
• Biotechnology (Genetics and Biosynthesis)
• Brand Building (Consumer Packaged Goods)
• Delivery Services
• End-to-end Manufacturing Services
• IP around bioavailability & on/offset time
• Medical Dosing Technology